Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
TELEFLEX INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
TELEFLEX INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
TELEFLEX INC
SIC 3841 · Surgical & Medical Instruments & Apparatus
Support
about
terms
$
TFX
TELEFLEX INC
CIK:
0000096943
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
6 Months Ended
Jun. 30, 2026
Jun. 29, 2025
Jun. 30, 2026
Jun. 29, 2025
Income Statement [Abstract]
Net revenues
$ 570,332
$ 442,525
$ 1,118,594
$ 856,783
Cost of goods sold
238,625
176,695
479,461
335,522
Gross profit
331,707
265,830
639,133
521,261
Selling, general and administrative expenses
213,515
137,504
439,527
290,419
Research and development expenses
45,122
26,488
89,508
51,783
Restructuring charges, separation costs and impairment charges
246
10,700
17,091
12,122
Income from continuing operations before interest, taxes and loss on extinguishment of debt
72,824
91,138
93,007
166,937
Interest expense
27,953
21,703
53,671
40,240
Interest income
(1,416)
(1,229)
(3,124)
(2,717)
Loss on extinguishment of debt
1,150
0
1,150
0
Income from continuing operations before taxes
45,137
70,664
41,310
129,414
Taxes on income from continuing operations
3,375
2,489
4,386
8,906
Income from continuing operations
41,762
68,175
36,924
120,508
Operating income from discontinued operations
60,254
64,577
57,611
114,637
Taxes on operating income from discontinued operations
2,323
10,172
2,996
17,563
Income from discontinued operations
57,931
54,405
54,615
97,074
Net income
$ 99,693
$ 122,580
$ 91,539
$ 217,582
Basic:
Income from continuing operations (in dollars per share)
$ 0.96
$ 1.54
$ 0.84
$ 2.68
Income from discontinued operations (in dollars per share)
1.33
1.23
1.24
2.15
Net income (in dollars per share)
2.29
2.77
2.08
4.83
Diluted:
Income from continuing operations (in dollars per share)
0.96
1.54
0.84
2.67
Income from discontinued operations(in dollars per share)
1.32
1.23
1.24
2.15
Net income (in dollars per share)
$ 2.28
$ 2.77
$ 2.08
$ 4.82
Weighted average common shares outstanding
Basic (in shares)
43,562
44,269
43,908
45,017
Diluted (in shares)
43,660
44,332
44,014
45,120
v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 29, 2025
Cash flows from operating activities of continuing operations:
Net income
$ 91,539
$ 217,582
Adjustments to reconcile net income to net cash provided by operating activities:
(Income) loss from discontinued operations
(54,615)
(97,074)
Depreciation expense
35,620
24,840
Intangible asset amortization expense
67,943
50,668
Deferred financing costs and debt discount amortization expense
2,976
1,705
Loss on extinguishment of debt
1,150
0
Changes in contingent consideration
(2,699)
14,080
Stock-based compensation
12,182
12,287
Asset impairment charge
0
8,117
Gain on non-designated foreign currency forward contracts
0
(83,532)
Deferred income taxes, net
(16,090)
(1,935)
Interest benefit on swaps designated as net investment hedges
(15,422)
(7,484)
Other
3,140
(6,388)
Changes in assets and liabilities, net of effects of acquisitions and disposals:
Accounts receivable
(23,639)
(26,559)
Inventories
44,252
(13,949)
Prepaid expenses and other assets
12,888
(3,734)
Accounts payable, accrued expenses and other liabilities
(6,053)
(27,643)
Income taxes receivable and payable, net
(14,613)
(70,277)
Net cash provided by (used in) operating activities from continuing operations
138,559
(9,296)
Cash flows from investing activities of continuing operations:
Expenditures for property, plant and equipment
(32,825)
(51,921)
Payments for businesses and intangibles acquired, net of cash acquired
0
(6,700)
Insurance settlement proceeds
0
9,447
Net payments on swaps designated as net investment hedges
(39,542)
7,612
Purchase of investments
(9,000)
(5,000)
Net cash used in investing activities from continuing operations
(81,367)
(46,562)
Cash flows from financing activities of continuing operations:
Proceeds from new borrowings
2,350,000
300,000
Reduction in borrowings
(2,175,000)
(55,375)
Repurchase of common stock
(250,000)
(300,000)
Net (payments) proceeds from share based compensation plans and related tax impacts
(5,265)
7,207
Share repurchase excise tax
(2,802)
(1,894)
Payments for contingent consideration
(107)
(112)
Dividends paid
(29,830)
(30,218)
Debt issuance and amendment fees
(13,981)
(2,800)
Net cash used in financing activities from continuing operations
(126,985)
(83,192)
Cash flows from discontinued operations:
Net cash provided by operating activities
4,796
90,131
Net cash used in investing activities
(18,144)
(12,718)
Net cash (used in) provided by discontinued operations
(13,348)
77,413
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents
(6,420)
17,908
Net decrease in cash, cash equivalents and restricted cash equivalents
(89,561)
(43,729)
Cash, cash equivalents and restricted cash equivalents at the beginning of the period
453,848
327,650
Less: Cash, cash equivalents and restricted cash of discontinued operations
(47,368)
(27,365)
Cash, cash equivalents and restricted cash equivalents at the end of the period
$ 316,919
$ 256,556
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Current assets
Cash and cash equivalents
$ 300,159
$ 378,564
Accounts receivable, net
364,609
345,583
Inventories
351,912
404,395
Prepaid expenses and other current assets
148,222
150,678
Prepaid taxes
36,458
19,566
Current assets of discontinued operations
674,516
639,552
Total current assets
1,875,876
1,938,338
Property, plant and equipment, net
475,637
498,281
Operating lease assets
77,158
91,817
Goodwill
2,292,435
2,305,050
Intangible assets, net
1,448,669
1,524,150
Deferred tax assets
12,642
12,593
Other assets
120,310
112,984
Non-current assets of discontinued operations
484,051
464,026
Total assets
6,786,778
6,947,239
Current liabilities
Current borrowings
87,500
100,000
Accounts payable
143,292
130,201
Accrued expenses
134,170
117,350
Payroll and benefit-related liabilities
110,214
124,769
Accrued interest
3,558
5,404
Income taxes payable
17,787
18,787
Other current liabilities
88,364
137,195
Current liabilities of discontinued operations
135,494
128,320
Total current liabilities
720,379
762,026
Long-term borrowings
2,720,509
2,541,449
Deferred tax liabilities
146,141
183,749
Noncurrent liability for uncertain tax positions
3,802
3,536
Noncurrent operating lease liabilities
64,540
84,210
Other liabilities
174,899
194,532
Non-current liabilities of discontinued operations
51,974
52,969
Total liabilities
3,882,244
3,822,471
Commitments and contingencies
Total shareholders' equity
2,904,534
3,124,768
Total liabilities and shareholders' equity
$ 6,786,778
$ 6,947,239